Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/36851
Type
ArticleCopyright
Restricted access
Collections
- BA - IGM - Artigos de Periódicos [3588]
- INI - Artigos de Periódicos [3397]
- IOC - Artigos de Periódicos [12500]
Metadata
Show full item record
GLOPID-R REPORT ON CHIKUNGUNYA, O'NYONG-NYONG AND MAYARO VIRUS, PART 2: EPIDEMIOLOGICAL DISTRIBUTION OF O'NYONG-NYONG VIRUS
O'nyong-nyong Virus
História Natural das Doenças
Soroprevalência
Epidemiologia
O'nyong-nyong Virus
Natural History of Diseases
Soroprevalence
Epidemiology
Siqueira, A. M.; Brasil, P. Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta à informação no documento.
Lourenço-de-Oliveira, R.; Rosa-Freitas, M. G. Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Mosquitos Transmissores de Hematozoários. Rio de Janeiro, RJ, Brasil.
a Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France b EA7310, Laboratoire de Virologie, Université de Corse-Inserm, Corte, France c Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, USA d Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands e Department Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands f Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, And Berlin Institute of Health, Institute of Virology, 10117, Berlin, Germany g German Centre for Infection Research (DZIF), Germany h Department of Pathology, Institute of Human Infection and Immunity, University of Texas Medical Branch, Galveston, USA i Unité D'Entomologie Médicale, Institut Pasteur de Dakar, Dakar, Senegal j Laveran Military Teaching Hospital, Marseille, France k Section Clinical Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany l Établissement Français Du Sang Alpes Méditerranée, Marseille, France m Department of Virology, Institut Pasteur, Arboviruses and Insect Vectors Unit, Paris, France n Institute for Human Infections and Immunity and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, USA o Medical Entomology Platform, Institut Pasteur Du Cambodge, Phnom Penh, Cambodia p Instituto Nacional de Infectologia Evandro Chagas - Oswaldo Cruz Foundation, Rio de Janeiro, Brazil q Blood Systems Research Institute, San Francisco, and Department of Laboratory Medicine, University of California, San Francisco, USA r Department of Medicine, and the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA s Department of Molecular Microbiology, And the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA t Department of Pathology and Immunology, And the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA u Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada v MRC-University of Glasgow Centre for Virus Research, Glasgow, UK w Institut Pasteur, Biology of Infection Unit, Inserm U1117, Paris Descartes University, Departement of Infectious Diseases and Tropical Medicine, Necker-Enfants Malades University Hospital, APHP, IHU Imagine, Paris, France x Instituto Oswaldo Cruz-Fiocruz, Laboratório de Mosquitos Transmissores de Hematozoários, Rio de Janeiro, Brazil y KU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium z Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore aa Gonçalo Moniz Institute, Oswaldo Cruz Foundation, And Federal University of Bahia, Salvador, Brazil ab Division of Emerging and Transfusion Transmitted Diseases, Laboratory of Emerging Pathogens, Office of Blood Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA ac Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Colombia.
Author
Pezzi, L.
LaBeaud, A. D.
Reusken, C. B.
Drexler, Jan Felix
Vasilakis, N.
Diallo, M.
Simon, F.
Jaenisch, T.
Gallian, P.
Sall, A.
Failloux, A. B.
Weaver, S. C.
Lamballerie, X. de
Boyero, S.
Brasil, P.
Busch, M.
Diamond, M. S.
Drebot, M. A.
Kohl, A.
Lecuit, M.
Oliveira, Ricardo Lourenço de
Neytsy, J.
Ng, Lfp
Ribeiro, Guilherme de Sousa
Rios, M.
Rodriguez-Morales, A. J.
Freitas, M. G. Rosa
Simmons, G.
Siqueira, A. M.
Ruaae, A. Vega
LaBeaud, A. D.
Reusken, C. B.
Drexler, Jan Felix
Vasilakis, N.
Diallo, M.
Simon, F.
Jaenisch, T.
Gallian, P.
Sall, A.
Failloux, A. B.
Weaver, S. C.
Lamballerie, X. de
Boyero, S.
Brasil, P.
Busch, M.
Diamond, M. S.
Drebot, M. A.
Kohl, A.
Lecuit, M.
Oliveira, Ricardo Lourenço de
Neytsy, J.
Ng, Lfp
Ribeiro, Guilherme de Sousa
Rios, M.
Rodriguez-Morales, A. J.
Freitas, M. G. Rosa
Simmons, G.
Siqueira, A. M.
Ruaae, A. Vega
Affilliation
Múltipla - ver em Notas.
Abstract
The GloPID-R (Global Research Collaboration for Infectious Disease Preparedness) chikungunya (CHIKV), o'nyong-nyong (ONNV) and Mayaro virus (MAYV) Working Group has been established to identify gaps of knowledge about the natural history, epidemiology and medical management of infection by these viruses, and to provide adapted recommendations for future investigations. Here, we present a report dedicated to ONNV epidemiological distribution. Two large-scale ONNV outbreaks have been identified in Africa in the last 60 years, interspersed with sporadic serosurveys and case reports of returning travelers. The assessment of the real scale of ONNV circulation in Africa remains a difficult task and surveillance studies are necessary to fill this gap. The identification of ONNV etiology is made complicated by the absence of multiplex tools in co-circulation areas and that of reference standards, as well as the high cross-reactivity with related pathogens observed in serological tests, in particular with CHIKV. This is a specific obstacle for seroprevalence studies, that necessitate an improvement of serological tools to provide robust results. The scarcity of existent genetic data currently limits molecular epidemiology studies. ONNV epidemiology would also benefit from reinforced entomological and environmental surveillance. Finally, the natural history of the disease deserves to be further investigated, with a specific attention paid to long-term complications. Considering our incomplete knowledge on ONNV distribution, GloPID-R CHIKV, ONNV and MAYV experts recommend that a major effort should be done to fill existing gaps.
Keywords in Portuguese
Virus ChikungunyaO'nyong-nyong Virus
História Natural das Doenças
Soroprevalência
Epidemiologia
Keywords
Chikungunya virusO'nyong-nyong Virus
Natural History of Diseases
Soroprevalence
Epidemiology
Publisher
Elsevier Masson
Citation
PEZZI, L. et al. GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 2: Epidemiological distribution of o'nyong-nyong virus. Antiviral Research, v. 172, p. 1-8, 2019.DOI
10.1016/j.antiviral.2019.104611ISSN
0166-3542Notes
Ribeiro, Guilherme de Sousa. Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta à informação no documento.Siqueira, A. M.; Brasil, P. Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta à informação no documento.
Lourenço-de-Oliveira, R.; Rosa-Freitas, M. G. Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Mosquitos Transmissores de Hematozoários. Rio de Janeiro, RJ, Brasil.
a Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France b EA7310, Laboratoire de Virologie, Université de Corse-Inserm, Corte, France c Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, USA d Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands e Department Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands f Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, And Berlin Institute of Health, Institute of Virology, 10117, Berlin, Germany g German Centre for Infection Research (DZIF), Germany h Department of Pathology, Institute of Human Infection and Immunity, University of Texas Medical Branch, Galveston, USA i Unité D'Entomologie Médicale, Institut Pasteur de Dakar, Dakar, Senegal j Laveran Military Teaching Hospital, Marseille, France k Section Clinical Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany l Établissement Français Du Sang Alpes Méditerranée, Marseille, France m Department of Virology, Institut Pasteur, Arboviruses and Insect Vectors Unit, Paris, France n Institute for Human Infections and Immunity and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, USA o Medical Entomology Platform, Institut Pasteur Du Cambodge, Phnom Penh, Cambodia p Instituto Nacional de Infectologia Evandro Chagas - Oswaldo Cruz Foundation, Rio de Janeiro, Brazil q Blood Systems Research Institute, San Francisco, and Department of Laboratory Medicine, University of California, San Francisco, USA r Department of Medicine, and the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA s Department of Molecular Microbiology, And the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA t Department of Pathology and Immunology, And the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA u Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada v MRC-University of Glasgow Centre for Virus Research, Glasgow, UK w Institut Pasteur, Biology of Infection Unit, Inserm U1117, Paris Descartes University, Departement of Infectious Diseases and Tropical Medicine, Necker-Enfants Malades University Hospital, APHP, IHU Imagine, Paris, France x Instituto Oswaldo Cruz-Fiocruz, Laboratório de Mosquitos Transmissores de Hematozoários, Rio de Janeiro, Brazil y KU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium z Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore aa Gonçalo Moniz Institute, Oswaldo Cruz Foundation, And Federal University of Bahia, Salvador, Brazil ab Division of Emerging and Transfusion Transmitted Diseases, Laboratory of Emerging Pathogens, Office of Blood Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA ac Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Colombia.
Share